In this interview, Murthy Simhambhatla, president and CEO of SetPoint Medical, explains why he moved into the Medtech industry and how that path has positioned him to lead SetPoint Medical, one of the industry’s most promising start-ups.
President and CEO
Murthy Simhambhatla was formerly the President and Chief Executive Officer of Evolus, a medical aesthetics company with a lead biologic drug, DWP-450, which he led towards an IPO in 2018. Prior to Evolus, Dr. Simhambhatla was a Senior Vice President at Abbott Laboratories and President of Abbott Medical Optics, a $1B-plus global ophthalmic business focused on cataract and refractive surgery.
Meet Our Host
A follower and fan of medtech for nearly two decades, Tom Salemi is the former bureau chief, venture capital, at Elsevier Business Intelligence, where he oversaw coverage of venture investments in medtech.